Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications

por Gaonkar, Raghuvir Haridas, Schmidt, Yannik Tim, Mansi, Rosalba, Almeida-Hernandez, Yasser, Sanchez-Garcia, Elsa, Harms, Mirja, Münch, Jan, Fani, Melpomeni
Publicado 2023